The research team at Li Ka Shing Faculty of Medicine at the University of Hong Kong, HKUMed made a groundbreaking discovery that somatic deletion of a tumor suppressor gene, AKTIP (AKT interacting protein), can increase the growth of luminal breast cancer and develop resistance to hormone therapy.
The research conclusion was published in the journal Cell Reports in December 2022.
